Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect

Xinping Fu, Lihua Tao, Aiwu Jin, Richard Geoffrey Vile, Malcolm K. Brenner, Xiaoliu Zhang

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Oncolytic viruses have shown considerable promise in the treatment of solid tumors, but their potency must be improved if their full clinical potential is to be realized. We inserted the gene encoding a truncated form of the gibbon ape leukemia virus envelope fusogenic membrane glycoprotein (GALV.fus) into an oncolytic herpes simplex virus, using an enforced ligation procedure. Subsequent in vitro and in vivo studies showed that expression of GALV.fus in the context of an oncolytic virus significantly enhances the antitumor effect of the virus. Furthermore, by controlling GALV.fus expression through a strict late viral promoter, whose activity depends on the initiation of viral DNA replication, we were able to express this glycoprotein in tumor cells but not in normal nondividing cells. It will be of interest to confirm whether functional expression of a strong fusogenic gene by an oncolytic herpes simplex virus enhances viral antitumor activity without increasing its toxicity.

Original languageEnglish (US)
Pages (from-to)748-754
Number of pages7
JournalMolecular Therapy
Volume7
Issue number6
DOIs
StatePublished - Jun 1 2003

Fingerprint

Gibbon ape leukemia virus
Oncolytic Viruses
Membrane Glycoproteins
Simplexvirus
Viral DNA
DNA Replication
Genes
Ligation
Neoplasms
Glycoproteins
Viruses

Keywords

  • Fusogenic membrane glycoprotein
  • Herpes simplex virus
  • Late viral promoter
  • Liver cancer
  • Oncolytic

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect. / Fu, Xinping; Tao, Lihua; Jin, Aiwu; Vile, Richard Geoffrey; Brenner, Malcolm K.; Zhang, Xiaoliu.

In: Molecular Therapy, Vol. 7, No. 6, 01.06.2003, p. 748-754.

Research output: Contribution to journalArticle

Fu, Xinping ; Tao, Lihua ; Jin, Aiwu ; Vile, Richard Geoffrey ; Brenner, Malcolm K. ; Zhang, Xiaoliu. / Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect. In: Molecular Therapy. 2003 ; Vol. 7, No. 6. pp. 748-754.
@article{5298dde8930849279ac6d6be4f670c56,
title = "Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect",
abstract = "Oncolytic viruses have shown considerable promise in the treatment of solid tumors, but their potency must be improved if their full clinical potential is to be realized. We inserted the gene encoding a truncated form of the gibbon ape leukemia virus envelope fusogenic membrane glycoprotein (GALV.fus) into an oncolytic herpes simplex virus, using an enforced ligation procedure. Subsequent in vitro and in vivo studies showed that expression of GALV.fus in the context of an oncolytic virus significantly enhances the antitumor effect of the virus. Furthermore, by controlling GALV.fus expression through a strict late viral promoter, whose activity depends on the initiation of viral DNA replication, we were able to express this glycoprotein in tumor cells but not in normal nondividing cells. It will be of interest to confirm whether functional expression of a strong fusogenic gene by an oncolytic herpes simplex virus enhances viral antitumor activity without increasing its toxicity.",
keywords = "Fusogenic membrane glycoprotein, Herpes simplex virus, Late viral promoter, Liver cancer, Oncolytic",
author = "Xinping Fu and Lihua Tao and Aiwu Jin and Vile, {Richard Geoffrey} and Brenner, {Malcolm K.} and Xiaoliu Zhang",
year = "2003",
month = "6",
day = "1",
doi = "10.1016/S1525-0016(03)00092-3",
language = "English (US)",
volume = "7",
pages = "748--754",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect

AU - Fu, Xinping

AU - Tao, Lihua

AU - Jin, Aiwu

AU - Vile, Richard Geoffrey

AU - Brenner, Malcolm K.

AU - Zhang, Xiaoliu

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Oncolytic viruses have shown considerable promise in the treatment of solid tumors, but their potency must be improved if their full clinical potential is to be realized. We inserted the gene encoding a truncated form of the gibbon ape leukemia virus envelope fusogenic membrane glycoprotein (GALV.fus) into an oncolytic herpes simplex virus, using an enforced ligation procedure. Subsequent in vitro and in vivo studies showed that expression of GALV.fus in the context of an oncolytic virus significantly enhances the antitumor effect of the virus. Furthermore, by controlling GALV.fus expression through a strict late viral promoter, whose activity depends on the initiation of viral DNA replication, we were able to express this glycoprotein in tumor cells but not in normal nondividing cells. It will be of interest to confirm whether functional expression of a strong fusogenic gene by an oncolytic herpes simplex virus enhances viral antitumor activity without increasing its toxicity.

AB - Oncolytic viruses have shown considerable promise in the treatment of solid tumors, but their potency must be improved if their full clinical potential is to be realized. We inserted the gene encoding a truncated form of the gibbon ape leukemia virus envelope fusogenic membrane glycoprotein (GALV.fus) into an oncolytic herpes simplex virus, using an enforced ligation procedure. Subsequent in vitro and in vivo studies showed that expression of GALV.fus in the context of an oncolytic virus significantly enhances the antitumor effect of the virus. Furthermore, by controlling GALV.fus expression through a strict late viral promoter, whose activity depends on the initiation of viral DNA replication, we were able to express this glycoprotein in tumor cells but not in normal nondividing cells. It will be of interest to confirm whether functional expression of a strong fusogenic gene by an oncolytic herpes simplex virus enhances viral antitumor activity without increasing its toxicity.

KW - Fusogenic membrane glycoprotein

KW - Herpes simplex virus

KW - Late viral promoter

KW - Liver cancer

KW - Oncolytic

UR - http://www.scopus.com/inward/record.url?scp=0037598911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037598911&partnerID=8YFLogxK

U2 - 10.1016/S1525-0016(03)00092-3

DO - 10.1016/S1525-0016(03)00092-3

M3 - Article

C2 - 12788648

AN - SCOPUS:0037598911

VL - 7

SP - 748

EP - 754

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 6

ER -